Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Daniel Åhs"'
Autor:
Daniel Åhs, Josefin Olausson, Jan-Erik Damber, Ingela Franck Lissbrant, Karin Welén, Åsa Jellvert
Publikováno v:
Acta oncologica (Stockholm, Sweden). 57(7)
Low-dose metronomic chemotherapy (LDMC) is an alternative for treatment of patients with late-stage prostate cancer (PC) not susceptible to regular chemotherapy due to its severe side effects. The exact working mechanisms of LDMC have not been establ
Autor:
Andreas Josefsson, Karin Welén, Jan-Erik Damber, Helena Brisby, Karin Larsson, Marianne Månsson, Jens Björkman, Daniel Åhs, Eva Rohlova
Publikováno v:
Oncotarget
Circulating tumor cells (CTCs) are promising biomarkers in prostate cancer (PC) because they derive from primary tumor and metastatic tissues. In this study, we used quantitative real-time PCR (qPCR) to compare the expression profiles of 41 PC-relate
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5e36d5df38ceec4814fbc23999857d08
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159988
http://urn.kb.se/resolve?urn=urn:nbn:se:umu:diva-159988
Publikováno v:
Cancer Research. 78:B071-B071
Background: Circulating tumor cells (CTC) are promising biomarkers in advanced prostate cancer. Since they are seeded from metastases, they may also serve as liquid biopsies for skeletal metastases that are difficult to sample. The aim of the present
Publikováno v:
Cancer Research. 78:B082-B082
Background: Prostate cancer (PC) mainly metastasizes to the bone, which is why the bone marrow is an organ of interest when investigating mechanisms for metastasis. Earlier studies have shown that primary tumors have the capability to affect target o